HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis

Experimental Neurology

Volumn 271, Issue , 2015, Pages 189-197

  Muth, Ingrid E ^a   Zschüntzsch, Jana ^a   Kleinschnitz, Konstanze ^a,b   Wrede, Arne ^a   Gerhardt, Ellen ^a   Balcarek, Peter ^a   Schreiber Katz, Olivia ^c   Zierz, Stephan ^d   Dalakas, Marinos C ^e,f   Voll, Reinhard E ^g   Schmidt, Jens ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Gemeinnutzige Hertie Stiftung   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

High mobility group box 1; Inclusion body myositis; Receptor for advanced glycation endproducts; Amyloid

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFILAMENT PROTEIN; TAU PROTEIN; AGER PROTEIN, HUMAN; CYTOKINE; HMGB1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ARTICLE; CELL DEATH; CELL STRESS; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWNSTREAM PROCESSING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; MOLECULAR MECHANICS; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MUSCULOSKELETAL SYSTEM INFLAMMATION; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; BIOPSY; CELL CULTURE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MUSCLE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TIME;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; BIOPSY; CELL DEATH; CELLS, CULTURED; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE CELLS; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; RNA, MESSENGER; TAU PROTEINS; TIME FACTORS;

EID: 84931263165     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.05.023     Document Type: Article

References (41)

1. Adams V., Nehrhoff B., Spate U., Linke A., Schulze P.C., Baur A., et al. Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc. Res. 2002, 54(1):95-104.
2. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192(4):565-570.
3. Askanas V., Engel W.K., Nogalska A. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J. Neuropathol. Exp. Neurol. 2012, 71(8):680-693.
4. Dalakas M.C. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nat. Clin. Pract. Neurol. 2006, 2(8):437-447.
5. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362(9388):971-982.
6. Das L., Blumbergs P.C., Manavis J., Limaye V.S. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Appl. Immunohistochem. Mol. Morphol. 2013, 21(6):539-542.
7. De Paepe B., Creus K.K., De Bleecker J.L. Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 2009, 21(6):610-616.
8. Du Y.S., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(10):5296-5301.
9. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3(10):995-1001.
10. Grundtman C., Bruton J., Yamada T., Ostberg T., Pisetsky D.S., Harris H.E., et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 2010, 24(2):570-578.
11. Harris H.E., Andersson U., Pisetsky D.S. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 2012, 8(4):195-202.
12. Haslbeck K.M., Friess U., Schleicher E.D., Bierhaus A., Nawroth P.P., Kirchner A., et al. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Acta Neuropathol. 2005, 110(3):247-254.
13. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270(43):25752-25761.
14. Keller C.W., Schmitz M., Munz C., Lunemann J.D., Schmidt J. TNF-alpha upregulates macroautophagic processing of APP/beta-amyloid in a human rhabdomyosarcoma cell line. J. Neurol. Sci. 2013, 325(1-2):103-107.
15. Kim G.T., Cho M.L., Park Y.E., Yoo W.H., Kim J.H., Oh H.J., et al. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin. Rheumatol. 2010, 29(3):273-279.
16. Kim S.W., Lim C.M., Kim J.B., Shin J.H., Lee S., Lee M., et al. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox. Res. 2011, 20:159-169.
17. Kokkola R., Li J., Sundberg E., Aveberger A.C., Palmblad K., Yang H., et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 2003, 48(7):2052-2058.
18. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 2003, 9(1-2):37-45.
19. Nagaraju K., Raben N., Merritt G., Loeffler L., Kirk K., Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin. Exp. Immunol. 1998, 113(3):407-414.
20. Nagaraju K., Casciola-Rosen L., Lundberg I., Rawat R., Cutting S., Thapliyal R., et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis - potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005, 52(6):1824-1835.
21. Porto A., Palumbo R., Pieroni M., Aprigliano G., Chiesa R., Sanvito F., et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J. 2006, 20(14):2565-2566.
22. Preibisch S., Saalfeld S., Tomancak P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 2009, 25(11):1463-1465.
23. Raju R., Vasconcelos O., Granger R., Dalakas M.C. Expression of IFN-gamma-inducible chemokines in inclusion body myositis. J. Neuroimmunol. 2003, 141(1-2):125-131.
24. Rose M. 188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 2013.
25. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418(6894):191-195.
26. Schmidt J., Dalakas M.C. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives. Expert. Rev. Clin. Immunol. 2013, 9(11):1125-1133.
27. Schmidt J., Rakocevic G., Raju R., Dalakas M.C. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8(+) T cell cytotoxicity. Brain 2004, 127:1182-1190.
28. Schmidt J., Barthel K., Wrede A., Salajegheh M., Bahr M., Dalakas M.C. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 2008, 131(Pt 5):1228-1240.
29. Schmidt J., Barthel K., Zschuntzsch J., Muth I.E., Swindle E.J., Hombach A., et al. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1beta-induced accumulation of beta-amyloid and cell death. Brain 2012, 135(Pt 4):1102-1114.
30. Schreiner B., Voss J., Wischhusen J., Dombrowski Y., Steinle A., Lochmuller H., et al. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 2006, 20(1):118-120.
31. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 2008, 180(4):2531-2537.
32. Tzeng H.P., Fan J., Vallejo J.G., Dong J.W., Chen X., Houser S.R., et al. Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 294(3):H1490-H1496.
33. Ulfgren A.K., Grundtman C., Borg K., Alexanderson H., Andersson U., Harris H.E., et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 2004, 50(5):1586-1594.
34. Urbonaviciute V., Furnrohr B.G., Weber C., Haslbeck M., Wilhelm S., Herrmann M., et al. Factors masking HMGB1 in human serum and plasma. J. Leukoc. Biol. 2007, 81(1):67-74.
35. van der Pas J., Hengstman G.J.D., ter Laak H.J., Borm G.F., van Engelen B.G.M. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J. Neurol. Neurosurg. Psychiatry 2004, 75(1):136-139.
36. Wilczynski G.M., Engel W.K., Askanas V. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation. Am. J. Pathol. 2000, 156:1835-1840.
37. Yan S.S., Chen D., Yan S., Guo L., Du H., Chen J.X. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. Front. Biosci. (Schol. Ed.) 2012, 4:240-250.
38. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(1):296-301.
39. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., Oppenheim J.J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 2007, 81(1):59-66.
40. Yin Q.Q., Dong C.F., Dong S.Q., Dong X.L., Hong Y., Hou X.Y., et al. AGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neurons. Cell. Mol. Neurobiol. 2012, 32(8):1299-1309.
41. Zong M., Bruton J.D., Grundtman C., Yang H., Li J.H., Alexanderson H., et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann. Rheum. Dis. 2013, 72(8):1390-1399.